Northwest Biotherapeutics Inc (NWBO) stock
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026Market cap $254.79MP/E –Yield –
Northwest Biotherapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Northwest Biotherapeutics's total debt was $12.24M at Jun 30, 2026. For fiscal 2025 it was $12.33M, down 0.5% from the year before. The highest annual figure on record is $25.16M in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.33M | -0.5% |
| FY2024 | Dec 31, 2024 | $12.40M | -39.0% |
| FY2023 | Dec 31, 2023 | $20.31M | +239.0% |
| FY2022 | Dec 31, 2022 | $5.99M | -76.2% |
| FY2021 | Dec 31, 2021 | $25.16M | +195.7% |
| FY2020 | Dec 31, 2020 | $8.51M | +29.1% |
| FY2019 | Dec 31, 2019 | $6.59M | +231.7% |
| FY2018 | Dec 31, 2018 | $1.99M | -20.8% |
| FY2017 | Dec 31, 2017 | $2.51M | -16.4% |
| FY2016 | Dec 31, 2016 | $3.00M | – |
| FY2015 | Dec 31, 2015 | $0 | -100.0% |
| FY2014 | Dec 31, 2014 | $50.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $12.24M | +33.5% |
| Q1 FY2026 | Mar 31, 2026 | $7.20M | +1.9% |
| Q4 FY2025 | Dec 31, 2025 | $12.33M | -0.5% |
| Q3 FY2025 | Sep 30, 2025 | $7.19M | -65.3% |
| Q2 FY2025 | Jun 30, 2025 | $9.17M | -55.1% |
| Q1 FY2025 | Mar 31, 2025 | $7.07M | -30.8% |
| Q4 FY2024 | Dec 31, 2024 | $12.40M | -39.0% |
| Q3 FY2024 | Sep 30, 2024 | $20.70M | +87.5% |
| Q2 FY2024 | Jun 30, 2024 | $20.43M | +29.8% |
| Q1 FY2024 | Mar 31, 2024 | $10.22M | -36.2% |
| Q4 FY2023 | Dec 31, 2023 | $20.31M | +239.0% |
| Q3 FY2023 | Sep 30, 2023 | $11.04M | +85.8% |
| Q2 FY2023 | Jun 30, 2023 | $15.74M | -4.3% |
| Q1 FY2023 | Mar 31, 2023 | $16.02M | -0.9% |
| Q4 FY2022 | Dec 31, 2022 | $5.99M | -76.2% |
| Q3 FY2022 | Sep 30, 2022 | $5.94M | -51.9% |
| Q2 FY2022 | Jun 30, 2022 | $16.46M | +32.8% |
| Q1 FY2022 | Mar 31, 2022 | $16.16M | +90.0% |
| Q4 FY2021 | Dec 31, 2021 | $25.16M | +188.9% |
| Q3 FY2021 | Sep 30, 2021 | $12.34M | +289.0% |
| Q2 FY2021 | Jun 30, 2021 | $12.40M | – |
| Q4 FY2020 | Dec 31, 2020 | $8.51M | +29.1% |
| Q3 FY2020 | Sep 30, 2020 | $8.71M | +30.9% |
| Q2 FY2020 | Jun 30, 2020 | $3.17M | -58.0% |
| Q1 FY2020 | Mar 31, 2020 | $0 | -100.0% |
| Q4 FY2019 | Dec 31, 2019 | $6.59M | +231.7% |
| Q3 FY2019 | Sep 30, 2019 | $6.65M | +45.1% |
| Q2 FY2019 | Jun 30, 2019 | $7.56M | +201.0% |
| Q1 FY2019 | Mar 31, 2019 | $4.00M | +56.1% |
| Q4 FY2018 | Dec 31, 2018 | $1.99M | -20.8% |
| Q3 FY2018 | Sep 30, 2018 | $4.58M | – |
| Q2 FY2018 | Jun 30, 2018 | $2.51M | -16.3% |
| Q1 FY2018 | Mar 31, 2018 | $2.56M | +5026.0% |
| Q4 FY2017 | Dec 31, 2017 | $2.51M | +4914.0% |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | $3.00M | – |
| Q2 FY2016 | Jun 30, 2016 | $50.00K | – |
| Q1 FY2016 | Mar 31, 2016 | $50.00K | – |
| Q4 FY2015 | Dec 31, 2015 | $0 | – |
See a number that looks wrong?